Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Minidosing Lysergic Acid Diethylamide (LSD) for Chronic Cluster Headache: a Randomized Placebo-controlled Study

NCT05477459 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05477459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05477459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Minidosing Lysergic Acid Diethylamide (LSD) for Chronic Cluster Headache: a Randomized Placebo-controlled Study
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
April 16, 2025
Completion date
April 30, 2027
Enrollment
65 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic cluster headache